Research graph
References from Association Between Proteinuria and Pregnancy Outcomes in Women With Preterm Pre‐Eclampsia Undergoing Expectant Management: Secondary Analysis of Two Randomised Trials. Local targets link to admitted publications; unresolved targets remain external evidence.
ACOG Practice Bulletin. Diagnosis and Management of Preeclampsia and Eclampsia. Number 33, January 2002
2002 · External reference
Hypertensive Disorders in Pregnancy: 2019 National Guideline
2019 · External reference
Diagnosis and Management of Hypertension in Pregnancy: Summary of Updated NICE Guidance
10.1136/bmj.l5119 · 2019 · External reference
Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222
10.1097/aog.0000000000003891 · 2020 · External reference
The 2021 International Society for the Study of Hypertension in Pregnancy Classification, Diagnosis & Management Recommendations for International Practice
10.1016/j.preghy.2021.09.008 · 2022 · External reference
Guideline No. 426: Hypertensive Disorders of Pregnancy: Diagnosis, Prediction, Prevention, and Management
10.1016/j.jogc.2022.03.002 · 2022 · External reference
Perinatal Outcomes in Preeclampsia That Is Complicated by Massive Proteinuria
10.1067/mob.2003.84 · 2003 · External reference
The Importance of Urinary Protein Excretion During Conservative Management of Severe Preeclampsia
10.1016/s0002-9378(96)70047-9 · 1996 · External reference
Urinary Protein‐To‐Creatinine Ratio: An Indicator of Adverse Clinical Outcomes in Preeclampsia With Proteinuria
2022 · External reference
Proteinuria in Pre‐Eclampsia: How Much Matters?
10.1111/j.1471-0528.2004.00395.x · 2005 · External reference
Outcome of Pregnancies Complicated by Severe Hypertension and Delivered Before 34 Weeks; Stepwise Logistic Regression Analysis of Prognostic Factors
10.1111/j.1471-0528.1989.tb03193.x · 1989 · External reference
Proteinuria in Preeclampsia: Not Essential to Diagnosis but Related to Disease Severity and Fetal Outcomes
10.1016/j.preghy.2017.03.005 · 2017 · External reference
The Impact of Proteinuria on Maternal and Perinatal Outcomes Among Women With Pre‐Eclampsia
10.1002/ijgo.12487 · 2018 · External reference
Is Massive Proteinuria Associated With Maternal and Fetal Morbidities in Preeclampsia?
10.5468/ogs.2017.60.3.260 · 2017 · External reference
Expectant Management of Early‐Onset Severe Preeclampsia: A Principal Component Analysis
10.21037/atm.2019.10.11 · 2019 · External reference
The Value of the 24‐h Proteinuria in Evaluating the Severity of Preeclampsia and Predicting Its Adverse Maternal Outcomes
10.1080/10641955.2018.1487564 · 2018 · External reference
Protein Creatinine Ratio in Random Urine Sample of Hypertensive Pregnant Women: Maternal and Perinatal Outcomes
10.3109/10641950903454564 · 2011 · External reference
Massive Urinary Protein Excretion Associated With Greater Neonatal Risk in Preeclampsia
10.1055/s-0037-1601866 · 2017 · External reference
Severe Proteinuria as a Parameter of Worse Perinatal/Neonatal Outcomes in Women With Preeclampsia
10.1016/j.preghy.2019.12.013 · 2020 · External reference
Proteinuria in Predicting Adverse Outcomes in Women With Severe Features of Pre‐Eclampsia From a Developing Country: A Prospective Cohort Study
10.1002/ijgo.15308 · 2024 · External reference
The Importance of Proteinuria in Preeclampsia and Its Predictive Role in Maternal and Neonatal Outcomes
10.1080/10641955.2019.1590718 · 2019 · External reference
Reappraisal of the Relationship Between 24‐Hour Proteinuria and Preeclampsia in Terms of the Maternal and Perinatal Outcomes
10.1080/10641955.2020.1725038 · 2020 · External reference
Urinary Protein Excretion and Expectant Management of Early Onset, Severe Pre‐Eclampsia
10.1016/s0020-7292(02)00008-5 · 2002 · External reference
Esomeprazole to Treat Women With Preterm Preeclampsia: A Randomised Placebo Controlled Trial
10.1016/j.ajog.2018.07.019 · 2018 · External reference
Use of Metformin to Prolong Gestation in Preterm Pre‐Eclampsia: Randomised, Double Blind, Placebo Controlled Trial
10.1136/bmj.n2103 · 2021 · External reference
Understanding Expectant Management of Pre‐Eclampsia
2016 · External reference
A Core Outcome Set for Pre‐Eclampsia Research: An International Consensus Development Study
10.1111/1471-0528.16319 · 2020 · External reference
Prediction of Adverse Maternal and Perinatal Outcomes Associated With Pre‐Eclampsia and Hypertensive Disorders of Pregnancy: A Systematic Review and Meta‐Analysis
10.1016/j.eclinm.2024.102861 · 2024 · External reference
Proteinuria During Pregnancy: Definition, Pathophysiology, Methodology, and Clinical Significance
10.1016/j.ajog.2020.08.108 · 2022 · External reference
Approach to Investigation and Management of Proteinuria in Pregnancy
10.1016/j.clinme.2024.100281 · 2025 · External reference
Consensus Definition of Fetal Growth Restriction: A Delphi Procedure
10.1002/uog.15884 · 2016 · External reference
Unresolved reference
External reference
Proteinuria May Be an Indicator of Adverse Pregnancy Outcomes in Patients With Preeclampsia: A Retrospective Study
10.1186/s12958-021-00751-y · 2021 · External reference
The Additive Role of Angiogenic Markers for Women With Confirmed Preeclampsia
10.1016/j.ajog.2022.10.044 · 2023 · External reference
The Impact of Proteinuria on Maternal and Perinatal Outcomes Among Women With Pre‐Eclampsia
10.1002/ijgo.12487 · ExternalCitation · doi-reference
Proteinuria in Predicting Adverse Outcomes in Women With Severe Features of Pre‐Eclampsia From a Developing Country: A Prospective Cohort Study
10.1002/ijgo.15308 · ExternalCitation · doi-reference
Consensus Definition of Fetal Growth Restriction: A Delphi Procedure
10.1002/uog.15884 · ExternalCitation · doi-reference
Esomeprazole to Treat Women With Preterm Preeclampsia: A Randomised Placebo Controlled Trial
10.1016/j.ajog.2018.07.019 · ExternalCitation · doi-reference
Proteinuria During Pregnancy: Definition, Pathophysiology, Methodology, and Clinical Significance
10.1016/j.ajog.2020.08.108 · ExternalCitation · doi-reference
The Additive Role of Angiogenic Markers for Women With Confirmed Preeclampsia
10.1016/j.ajog.2022.10.044 · ExternalCitation · doi-reference
Approach to Investigation and Management of Proteinuria in Pregnancy
10.1016/j.clinme.2024.100281 · ExternalCitation · doi-reference
Prediction of Adverse Maternal and Perinatal Outcomes Associated With Pre‐Eclampsia and Hypertensive Disorders of Pregnancy: A Systematic Review and Meta‐Analysis
10.1016/j.eclinm.2024.102861 · ExternalCitation · doi-reference
Guideline No. 426: Hypertensive Disorders of Pregnancy: Diagnosis, Prediction, Prevention, and Management
10.1016/j.jogc.2022.03.002 · ExternalCitation · doi-reference
Proteinuria in Preeclampsia: Not Essential to Diagnosis but Related to Disease Severity and Fetal Outcomes
10.1016/j.preghy.2017.03.005 · ExternalCitation · doi-reference
Severe Proteinuria as a Parameter of Worse Perinatal/Neonatal Outcomes in Women With Preeclampsia
10.1016/j.preghy.2019.12.013 · ExternalCitation · doi-reference
The 2021 International Society for the Study of Hypertension in Pregnancy Classification, Diagnosis & Management Recommendations for International Practice
10.1016/j.preghy.2021.09.008 · ExternalCitation · doi-reference
The Importance of Urinary Protein Excretion During Conservative Management of Severe Preeclampsia
10.1016/s0002-9378(96)70047-9 · ExternalCitation · doi-reference
Urinary Protein Excretion and Expectant Management of Early Onset, Severe Pre‐Eclampsia
10.1016/s0020-7292(02)00008-5 · ExternalCitation · doi-reference
Massive Urinary Protein Excretion Associated With Greater Neonatal Risk in Preeclampsia
10.1055/s-0037-1601866 · ExternalCitation · doi-reference
Perinatal Outcomes in Preeclampsia That Is Complicated by Massive Proteinuria
10.1067/mob.2003.84 · ExternalCitation · doi-reference
The Value of the 24‐h Proteinuria in Evaluating the Severity of Preeclampsia and Predicting Its Adverse Maternal Outcomes
10.1080/10641955.2018.1487564 · ExternalCitation · doi-reference
The Importance of Proteinuria in Preeclampsia and Its Predictive Role in Maternal and Neonatal Outcomes
10.1080/10641955.2019.1590718 · ExternalCitation · doi-reference
Reappraisal of the Relationship Between 24‐Hour Proteinuria and Preeclampsia in Terms of the Maternal and Perinatal Outcomes
10.1080/10641955.2020.1725038 · ExternalCitation · doi-reference
Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222
10.1097/aog.0000000000003891 · ExternalCitation · doi-reference
A Core Outcome Set for Pre‐Eclampsia Research: An International Consensus Development Study
10.1111/1471-0528.16319 · ExternalCitation · doi-reference
Outcome of Pregnancies Complicated by Severe Hypertension and Delivered Before 34 Weeks; Stepwise Logistic Regression Analysis of Prognostic Factors
10.1111/j.1471-0528.1989.tb03193.x · ExternalCitation · doi-reference
Proteinuria in Pre‐Eclampsia: How Much Matters?
10.1111/j.1471-0528.2004.00395.x · ExternalCitation · doi-reference
Diagnosis and Management of Hypertension in Pregnancy: Summary of Updated NICE Guidance
10.1136/bmj.l5119 · ExternalCitation · doi-reference
Use of Metformin to Prolong Gestation in Preterm Pre‐Eclampsia: Randomised, Double Blind, Placebo Controlled Trial
10.1136/bmj.n2103 · ExternalCitation · doi-reference
Proteinuria May Be an Indicator of Adverse Pregnancy Outcomes in Patients With Preeclampsia: A Retrospective Study
10.1186/s12958-021-00751-y · ExternalCitation · doi-reference
Expectant Management of Early‐Onset Severe Preeclampsia: A Principal Component Analysis
10.21037/atm.2019.10.11 · ExternalCitation · doi-reference
Protein Creatinine Ratio in Random Urine Sample of Hypertensive Pregnant Women: Maternal and Perinatal Outcomes
10.3109/10641950903454564 · ExternalCitation · doi-reference
Is Massive Proteinuria Associated With Maternal and Fetal Morbidities in Preeclampsia?
10.5468/ogs.2017.60.3.260 · ExternalCitation · doi-reference
